Table 2.
Seven- and 30-day mortality associated with IABP in patients with AMICS at different SCAI SHOCK stages
| 7-day mortality | 30-day mortality | |||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| PSM | ||||
| SCAI SHOCK stage A/B | 0.31 (0.05–1.30) | 0.147 | 0.19 (0.03–0.73) | 0.034 |
| SCAI SHOCK stage C/D/E | 1.39 (0.76–2.59) | 0.287 | 1.49 (0.84–2.65) | 0.172 |
| CBPS | ||||
| SCAI SHOCK stage A/B | 0.32 (0.07–1.51) | 0.148 | 0.22 (0.05–0.97) | 0.045 |
| SCAI SHOCK stage C/D/E | 1.50 (0.84–2.70) | 0.171 | 1.55 (0.90–2.67) | 0.110 |
CBPS, covariate balancing propensity score; CI, confidence interval; IABP, intra-aortic balloon pump; OR, odds ratio; PSM, propensity score matching.